Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamine.
J Occup Environ Med
; 45(3): 289-94, 2003 Mar.
Article
em En
| MEDLINE
| ID: mdl-12661186
ABSTRACT
Approximately 1800 workers in pipe manufacturing plants in the United States may have been exposed to beta-napthlyamnine between 1970 and 1996. Once the chemical was detected, the contaminated additive in the resin was identified and discontinued. A bladder cancer-screening program was initiated in 1999. An annual two-stage screening program was developed to test for microscopic hematuria (stage one) and cytology (stage two), with a urology referral of positive or suspicious cytology. This paper presents the program methodology, cohort enumeration, recruitment, and enrollment strategies, and screening protocol. Enrollment data from the first 3 years are presented. Annual screening of a cohort of current and former employees is feasible. Original personnel records are often incomplete, making cohort identification important. Personal contact and follow-up are key elements of successful recruitment and retention.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Bexiga Urinária
/
Indústria Química
/
2-Naftilamina
/
Doenças Profissionais
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article